Roche and Nurix strike $2.3 billion blood cancer drug deal
Roche and Nurix strike $2.3 billion blood cancer drug deal
Roche and Nurix strike $2.3 billion blood cancer drug deal
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.